Diabetes Dialogue: Oral Ozempic and the Risks of Compounding Formulas
Автор: HCPLive
Загружено: 2026-02-13
Просмотров: 52
Описание:
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!
In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, explore major updates in the evolving GLP-1 receptor agonist landscape, with a particular focus on oral semaglutide formulations, branding changes, and regulatory concerns surrounding compounded alternatives.
Catch up on previous episodes here: https://www.hcplive.com/podcasts/diab...
Key Episode Timestamps
00:00:01 Intro
00:00:25 Oral Wegovy and oral Ozempic
00:03:04 Why Rybelsus didn't work
00:05:33 The importance of administration
00:06:56 Compounding drugs - the Hims and Hers drama
00:07:56 The danger of unregulated compound drugs
00:11:50 Outro
#diabetes #endocrinology #hims #ozempic
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
